Medical Transcription Billing (MTBC) Posts Q2 Loss of 1c/Share

Medical Transcription Billing (NASDAQ: MTBC) reported Q2 EPS of ($0.01), $0.04 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $2.6 million versus the consensus estimate of $2.6 million.

For earnings history and earnings-related data on Medical Transcription Billing (MTBC) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Assembly Biosciences (ASMB) Tops Q2 EPS by 53c
• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance